Han Kim
About Han Kim
Han Kim is a Senior Director at Bolt Biotherapeutics, Inc., with extensive experience in oncology research and drug development. He holds a Ph.D. in Microbiology (Immunology) from Columbia University and has worked in various leadership roles across multiple organizations, including AbbVie and PDL BioPharma.
Current Role at Bolt Biotherapeutics
Han Kim serves as Senior Director at Bolt Biotherapeutics, Inc., a position he has held since 2021. In this role, he is based in Redwood City, California. His responsibilities include overseeing a team of 10 scientists and managing multiple programs that span from early discovery to clinical stages. This position emphasizes his leadership capabilities and project coordination skills within the biotechnology sector.
Experience at AbbVie
Han Kim has been with AbbVie since 2017, currently holding the title of Principal Scientist II-Translational Oncology Research Lead. His work focuses on directing pre-clinical translational activities that support indication selection and biomarker strategy. He previously served as Principal Scientist-Discovery Group Lead at AbbVie from 2010 to 2016, where he contributed to drug development initiatives in Redwood City, California.
Educational Background
Han Kim obtained his Ph.D. in Microbiology (Immunology) from Columbia University Vagelos College of Physicians and Surgeons, where he studied from 1995 to 2001. He also earned a Bachelor of Arts in Biochemistry from the University of Pennsylvania, completing his studies there from 1991 to 1995. His educational background provides a strong foundation for his work in translational oncology.
Previous Positions in Biotechnology
Prior to his current roles, Han Kim held several significant positions in the biotechnology field. He worked as a Group Leader in Oncology Target Validation at PDL BioPharma from 2005 to 2008 and as a Group Leader in Biomarker Discovery at Facet Biotech from 2008 to 2010. Additionally, he served as a Postdoctoral Researcher at Columbia University from 2001 to 2005, gaining valuable research experience.
Leadership and Project Management
In his current and previous roles, Han Kim has demonstrated strong leadership and project management skills. He manages a team of 10 scientists, overseeing various programs from early discovery to clinical stages. His strategic approach to drug development is evident in his guidance of next-generation ISAC platforms, integrating insights from both clinical and laboratory settings.